Posted by Michael Wonder on 07 Sep 2020
SMC - September 2020 decisions
7 September 2020 - The SMC has today published advice accepting fourteen new medicines.
Cannabidiol (Epidyolex) was accepted for the treatment of Lennox-Gastaut syndrome, a rare type of epilepsy that presents in early childhood.
Cannabidiol (Epidyolex) in combination with clobazam was also accepted for the treatment of Dravet syndrome, another rare type of epilepsy, following consideration through PACE.
